0000899243-22-014838.txt : 20220414 0000899243-22-014838.hdr.sgml : 20220414 20220414204438 ACCESSION NUMBER: 0000899243-22-014838 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210623 FILED AS OF DATE: 20220414 DATE AS OF CHANGE: 20220414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keresty Georgia CENTRAL INDEX KEY: 0001773532 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 22828777 MAIL ADDRESS: STREET 1: C/O ASPEN TECHNOLOGY, INC. STREET 2: 20 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-06-23 2021-06-25 0 0001652130 Intellia Therapeutics, Inc. NTLA 0001773532 Keresty Georgia C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130 CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2021-06-23 4 A 0 1569 0.00 A 6524 D Stock Option (right to buy) 83.59 2021-06-23 4 A 0 2534 0.00 A 2031-06-22 Common Stock 2534 2534 D Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. This option was granted on June 23, 2021 with respect to 2,534 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. The Form 4/A amends and restates the original Form 4 filed on June 25, 2021 to correct the number of shares of common stock and stock options granted to the reporting person. /s/James Basta, Attorney-In-Fact 2022-04-14